Molecular Therapy Nucleic Acids
Cas12a chRDNA-mediated in vivo genome editing for high specificity functional gene disruption
Experiments in animalsInterventions
The paper
Caribou Biosciences (United States)
Molecular Therapy Nucleic Acids, 2 Sep 2026